This funding opportunity supports small, self-contained clinical and translational science research projects such as pilot studies, secondary data analyses, and development of new methodologies or technologies. It targets KL2 scholars and CTSA re-entry supplement recipients to facilitate their transition to independent academic translational scientists. Projects may include patient-oriented research and aim to generate preliminary data for future larger grant applications. The award amount is $50,000 with a deadline of October 19, 2026.
Eligible applicants include a wide range of U.S. entities such as tribal governments, nonprofits, state and local governments, institutions of higher education, small businesses, and others. Foreign organizations are generally not eligible except for certain foreign components of U.S. organizations.
